Dr Jennie M Hunnewell, MD PLLC in Oklahoma City, OK - General Practice

Dr Jennie M Hunnewell, MD PLLC is a General Practice physician based in Oklahoma City, Oklahoma. Dr Jennie M Hunnewell is licensed to practice in Oklahoma (license number 20314) and her current practice location is 5101 W Memorial Rd, Oklahoma City, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (405) 463-5700.

NPI number for Dr Jennie M Hunnewell is 1548244387 and her current mailing address is 5025 Gaillardia Corporate Pl, Suite C, Oklahoma City, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1548244387.

Contact Information

	Dr Jennie M Hunnewell, MD PLLC
	5101 W Memorial Rd, Oklahoma City, OK 73142-2018
	(405) 463-5700
	(405) 463-5705

Physician's Profile

Full Name	Dr Jennie M Hunnewell
Gender	Female
Speciality	General Practice
Location	5101 W Memorial Rd, Oklahoma City, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1548244387
Provider Enumeration Date: 12/05/2005
Last Update Date: 09/29/2023

Medical Identifiers

Medical identifiers for Dr Jennie M Hunnewell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548244387	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	20314 (Oklahoma)	Secondary
208D00000X	General Practice	20314 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Jennie M Hunnewell is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Jennie M Hunnewell, MD PLLC 5025 Gaillardia Corporate Pl, Suite C, Oklahoma City, OK 73142-1888 Ph: (405) 463-5700	Dr Jennie M Hunnewell, MD PLLC 5101 W Memorial Rd, Oklahoma City, OK 73142-2018 Ph: (405) 463-5700

News Archive

Safeguard Scientifics reports net income of $24 million for fourth quarter 2013

Safeguard Scientifics, Inc. today announced fourth quarter and full-year 2013 financial results. For the three months ended December 31, 2013, Safeguard's net income was $24.0 million, or $1.10 per share, compared to net loss of $10.8 million, or $0.51 per share for the same period in 2012. For the year ended December 31, 2013, Safeguard's net loss was $35.5 million, or $1.66 per share, compared to $39.4 million, or $1.88 per share for the same period in 2012.

Ease of information capture and recordkeeping will help enable smoother transition to EHR systems

The proven ability of the medical transcription sector to deliver innovative, physician-friendly, and cost-effective solutions to the challenges of electronic health record (EHR) adoption will be the message taken to Capitol Hill by members of the Association for Healthcare Documentation Integrity (AHDI) and the Medical Transcription Industry Association (MTIA) for the organizations' fifth-annual Advocacy Summit on March 24 in Washington, DC.

Texas Public Policy Foundation says health plans would cause more harm than good

The health care reform plans pending in the U.S. Congress would cause more harm than good, according to a study released today by the Texas Public Policy Foundation.

Positive initial results from Nektar Therapeutics' NKTR-102 Phase 2 study for metastatic breast cancer

Nektar Therapeutics today announced positive preliminary initial results from a two-stage Phase 2 clinical study evaluating single-agent NKTR-102 in women with advanced/metastatic breast cancer patients who have received a prior taxane. The increased use of taxanes in breast cancer often renders tumors resistant to these drugs by the time the disease recurs, thereby underscoring the urgent need for new treatment options with novel mechanisms of action for metastatic disease.

Novel combination anti-psoriasis therapy targets genetic abnormalities in deeper layers of the skin

A novel combination anti-psoriasis therapy has potential for superior and longer-lasting therapeutic effects than current topical treatments by targeting genetic abnormalities in deeper layers of the skin. This research is being presented at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition, the world's largest pharmaceutical sciences meeting, in San Antonio, Nov. 10-14.

General Practice Doctors in Oklahoma City, OK

Dr. Jessica Marie Reyes Giusti, MD General Practice Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-1000
Dr. John Joseph Chiaffitelli, DO General Practice Medicare: Accepting Medicare Assignments Practice Location: 1601 Sw 89th St, Oklahoma City, OK 73159 Phone: 405-681-2273 Fax: 405-681-2274
Dr. William Douglas Mills, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 6500 S Macarthur Blvd, Faa-mmac Aam-300, Oklahoma City, OK 73169 Phone: 405-343-9432 Fax: 405-954-0260
Dr. David B Mallory, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1240 Sw 44th St, Oklahoma City, OK 73109 Phone: 405-631-1527 Fax: 405-631-9930
Dr. Darlene G. Johnson, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 9220 S Pennsylvania Ave, Suite B, Oklahoma City, OK 73159 Phone: 405-692-1331 Fax: 405-692-0082
Bruce D Thompson, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 4510 Nw 39th St, Oklahoma City, OK 73122 Phone: 405-495-5841
Dr. Joshua Alan Stevens, MD General Practice Medicare: Medicare Enrolled Practice Location: 301 Nw 6th St, Ste 150, Oklahoma City, OK 73102 Phone: 405-609-8700

Dr Jennie M Hunnewell, MD PLLC - General Practice in Oklahoma City, OK